Sunitinib combined with pemetrexed and carboplatin in patients with NSCLC and other advanced solid malignancies: maximum tolerated dose and safety results

被引：0
|
作者：
Chow, Laura Q. M. [1 ]
Blais, Normand [2 ]
Jonker, Derek J. [1 ]
Soulieres, Denis [2 ]
Laurie, Scott A. [1 ]
Diab, Sami G. [3 ]
Ruiz-Garcia, Ana [4 ]
Thall, Aron [4 ]
Chao, Richard [4 ]
Eckhardt, S. Gail [5 ]
Camidge, D. Ross [5 ]
机构：
[1] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[2] CHUM, Hop Notre Dame de Bon Secours, Montreal, PQ, Canada
[3] Rocky Mt Canc Ctr, Aurora, CO USA
[4] Pfizer Oncol, La Jolla, CA USA
[5] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S672 / S672
页数：1
相关论文
共 50 条
  • [1] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study
    Normand Blais
    D. Ross Camidge
    Derek J. Jonker
    Denis Soulières
    Scott A. Laurie
    Sami G. Diab
    Ana Ruiz-Garcia
    Aron Thall
    Ke Zhang
    Richard C. Chao
    Laura Q. Chow
    Investigational New Drugs, 2013, 31 : 1487 - 1498
  • [2] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study
    Blais, Normand
    Camidge, D. Ross
    Jonker, Derek J.
    Soulieres, Denis
    Laurie, Scott A.
    Diab, Sami G.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Chao, Richard C.
    Chow, Laura Q.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1487 - 1498
  • [3] Sunitinib combined with pemetrexed and cisplatin in patients with advanced solid malignancies: phase I dose escalation study
    Blais, N.
    Camidge, D. R.
    Jonker, D. J.
    Soulieres, D.
    Doebele, R. C.
    Ruiz-Garcia, A.
    Thall, A.
    Chao, R.
    Eckhardt, S. G.
    Chow, L. Q.
    EJC SUPPLEMENTS, 2009, 7 (02): : 552 - 552
  • [4] A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies
    Hartford, Christine M.
    Desai, Apurva A.
    Janisch, Linda
    Karrison, Theodore
    Rivera, Victor M.
    Berk, Lori
    Loewy, John W.
    Kindler, Hedy
    Stadler, Walter M.
    Knowles, Heather L.
    Bedrosian, Camille
    Ratain, Mark J.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1428 - 1434
  • [5] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [7] Phase I trial of ixabepilone administered as a 24-hour infusion in patients with advanced solid malignancies: updated safety profile and maximum tolerated dose
    Tan, A. R.
    Mekhail, T.
    Edelman, M. J.
    Iacono, L. C.
    Messina, M.
    Trifan, O. C.
    EJC SUPPLEMENTS, 2008, 6 (12): : 131 - 131
  • [8] Patupilone combined with carboplatin in patients (pts) with advanced solid tumors: preliminary safety and activity results
    Fracasso, P. M.
    Ravaud, A.
    Baggstrom, M. Q.
    LoRusso, P. M.
    Jones, D. V.
    Sguotti, C.
    Urban, P.
    Gao, B.
    Medioni, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
    Camidge, D. Ross
    Blais, Normand
    Jonker, Derek J.
    Soulieres, Denis
    Doebele, Robert C.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Laurie, Scott A.
    Chao, Richard C.
    Chow, Laura Q.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 307 - 319
  • [10] Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
    D. Ross Camidge
    Normand Blais
    Derek J. Jonker
    Denis Soulières
    Robert C. Doebele
    Ana Ruiz-Garcia
    Aron Thall
    Ke Zhang
    Scott A. Laurie
    Richard C. Chao
    Laura Q. Chow
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 307 - 319
12345